Your browser doesn't support javascript.
loading
Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG).
Matikas, A; Kentepozidis, Ν; Ardavanis, A; Vaslamatzis, M; Polyzos, A; Emmanouilides, Ch; Katsaounis, P; Koinis, F; Xynogalos, S; Christopoulou, A; Ziras, N; Tegos, Th; Prinarakis, E; Hatzidaki, D; Georgoulias, V; Kotsakis, A.
Afiliación
  • Matikas A; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Kentepozidis Ν; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Ardavanis A; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Vaslamatzis M; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Polyzos A; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Emmanouilides Ch; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Katsaounis P; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Koinis F; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Xynogalos S; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Christopoulou A; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Ziras N; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Tegos T; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Prinarakis E; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Hatzidaki D; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Georgoulias V; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece.
  • Kotsakis A; Hellenic Oncology Research Group (HORG), 55 Lomvardou Street, 11471, Athens, Greece. kotsakis@uoc.gr.
Cancer Chemother Pharmacol ; 78(2): 369-76, 2016 Aug.
Article en En | MEDLINE | ID: mdl-27335027
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Bevacizumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2016 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Bevacizumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2016 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Alemania